Incyte
INCY
#975
Rank
NZ$42.70 B
Marketcap
NZ$209.53
Share price
-1.07%
Change (1 day)
15.28%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2026 (TTM): NZ$3.56

According to Incyte's latest financial reports the company's current EPS (TTM) is NZ$3.84. In 2025 the company made an earnings per share (EPS) of NZ$12.06 an increase over its 2024 EPS that were of NZ$0.57.

EPS history for Incyte from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$3.56-70.49%
2025NZ$12.062029.03%
2024NZ$0.57-88.39%
2023NZ$4.8873.38%
2022NZ$2.82-64.1%
2021NZ$7.84-408.63%
2020NZ-$2.54-166.83%
2019NZ$3.80300%
2018NZ$0.95-133.33%
2017NZ-$2.85-378.57%
2016NZ$1.022700%
2015NZ$0.03656-106.67%
2014NZ-$0.55-44.44%
2013NZ-$0.9950%
2012NZ-$0.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$9.60 150.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.30-66.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$56.47 1,370.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$31.77 727.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$4.73 23.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
NZ-$0.15-103.81%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
NZ-$1.06-127.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
NZ-$1.54-140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
NZ-$0.40-110.48%๐Ÿ‡บ๐Ÿ‡ธ USA